Novel Therapies Targeting Endometriosis

被引:65
作者
Taylor, Hugh S. [1 ]
Osteen, Kevin G. [2 ]
Bruner-Tran, Kaylon L. [2 ]
Lockwood, Charles J. [1 ]
Krikun, Graciela [1 ]
Sokalska, Anna [3 ]
Duleba, Antoni J. [3 ]
机构
[1] Yale Univ, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT USA
[2] Vanderbilt Univ, Dept Obstet & Gynecol & Womens Hlth, Nashville, TN USA
[3] Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA
关键词
Endometriosis; ICON; tissue factor; statins; stem cells; SERM; SPRM; ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE EXPRESSION; ESTROGEN-RECEPTOR MODULATORS; TISSUE FACTOR; STEM-CELLS; IN-VITRO; PROTEIN PRENYLATION; PERITONEAL-FLUID; STROMAL CELLS; TUMOR-CELLS;
D O I
10.1177/1933719111410713
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis is an often painful disorder in which the endometrial glands and stroma grow outside the uterus. The disease affects women's quality of life and is a common cause of infertility. In this review, we describe promising new developments in the field based on in vitro assays and rodent models, each of which has the potential to be beneficial in the treatment of this disease. We will specifically describe the role of anti-inflammatory drugs, selective estrogen, or progesterone modulators, statins, antiangiogenic agents, and the potential for targeting stem cells as likely methods to hone in and eliminate endometriosis. The most promising of these potential therapies are currently slated for further testing in both rodent and nonhuman primate trials.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 108 条
[91]   Emx2 regulates mammalian reproduction by altering endometrial cell proliferation [J].
Taylor, HS ;
Fei, XL .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (11) :2839-2846
[92]   Angiogenic factors in endometriosis [J].
Taylor, RN ;
Lebovic, DI ;
Mueller, MD .
ENDOMETRIOSIS: EMERGING RESEARCH AND INTERVENTION STRATEGIES, 2002, 955 :89-100
[93]   Emerging role of genomics in endometriosis research [J].
Taylor, RN ;
Lundeen, SG ;
Giudice, LC .
FERTILITY AND STERILITY, 2002, 78 (04) :694-698
[94]  
Taylor RN, 2002, ANN NY ACAD SCI, V955, P118
[95]  
Toomey JR, 1996, BLOOD, V88, P1583
[96]  
Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21
[97]   Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis [J].
Vercellini, P ;
DeGiorgi, O ;
Oldani, S ;
Cortesi, I ;
Panazza, S ;
Crosignani, PG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (02) :396-401
[98]   Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity [J].
Versteeg, Henri H. ;
Ruf, Wolfram .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) :25416-25424
[99]   Emerging insights in tissue factor-dependent signaling events [J].
Versteeg, HH ;
Ruf, W .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (01) :24-32
[100]   Tissue factor signal transduction in angiogenesis [J].
Versteeg, HH ;
Peppelenbosch, MP ;
Spek, CA .
CARCINOGENESIS, 2003, 24 (06) :1009-1013